HTT and Huntington disease: Finally, there is evidence that CB1 activity is beneficial for the treatment of Huntington’s disease (HD), a genetic neurodegenerative disorder marked by expression of mutant Huntingtin (mHTT) protein with polyglutamine repeats, which forms aggregates that lead to striatal neurodegeneration and progressive motor dysfunction [37].